Peak absolute lymphocyte count after CAR-T infusion predicts clinical response in aggressive lymphoma.
Am J Hematol
; 97(7): E241-E244, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35385152
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Receptors, Chimeric Antigen
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2022
Type:
Article
Affiliation country:
United States